SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-063785
Filing Date
2024-03-08
Accepted
2024-03-08 17:13:02
Documents
15
Period of Report
2024-03-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d784350d8k.htm   iXBRL 8-K 39216
2 EX-99.1 d784350dex991.htm EX-99.1 17679
  Complete submission text file 0001193125-24-063785.txt   194653

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA grph-20240308.xsd EX-101.SCH 2849
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE grph-20240308_lab.xml EX-101.LAB 18736
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grph-20240308_pre.xml EX-101.PRE 11706
16 EXTRACTED XBRL INSTANCE DOCUMENT d784350d8k_htm.xml XML 3745
Mailing Address 611 GATEWAY BLVD, SUITE 120 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD, SUITE 120 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Filer) CIK: 0001815776 (see all company filings)

IRS No.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40532 | Film No.: 24735522
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)